GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Faster approvals likely to make CAR-T landscape competitive in China, says GlobalData

China’s National Medical Products Administration (NMPA) has approved its second chimeric antigen receptor T (CAR-T) cell immunotherapy product JW Therapeutics’ relmacabtagene autoleucel injection (relma-cel) shortly after the approval of its first CAR-T therapy, Gilead & FosunKite’s Yescarta, in June 2021. With several CAR-T therapies in Phase II pipeline in China, particularly dominated by domestic companies, […]
Read more

Enterprise server spending in Australia to increase at 6.3% CAGR over 2020-2025, forecasts GlobalData

The total addressable market size of enterprise servers in Australia, in terms of spending opportunity, is poised grow at a compound annual growth rate (CAGR) of 6.3% to reach US$1.3bn in 2025, led by the ongoing enterprise digital transformation initiatives and IT modernization efforts, says GlobalData, a leading data and analytics company. GlobalData’s latest report, […]
Read more

Amylyx’s ALS drug AMX0035 likely available much sooner than expected, says GlobalData

Following the recent shift in the FDA’s stance on Amylyx Pharmaceuticals’ AMX0035* new drug application (NDA), leading data and analytics company, GlobalData, expects that this drug could be available for amyotrophic lateral sclerosis (ALS) patients much sooner than anticipated. Sarah Elsayed, Neurology Analyst at GlobalData, comments: “As AMX0035 targets a serious neurological condition with huge […]
Read more

Vertex to replace Trikafta as gold standard treatment for cystic fibrosis but other CTFR therapies welcome, says GlobalData

Of the five late-stage pipeline products expected to be licensed in the 7MM* for cystic fibrosis (CF) between 2020 and 2030, four will be CF transmembrane conductance regulator (CFTR) modulators, according to GlobalData. The leading data and analytics company notes that Vertex’s next-generation triple combination, VX-121 + tezacaftor + VX-561 (deutivacaftor), is expected to replace […]
Read more

India’s make-up market growth to be led by quality-conscious, digitally savvy consumers, says GlobalData

The growth of make-up market in India is forecasted to grow at a compound annual growth rate (CAGR) of 9.6% from INR86.7bn (US$1.2bn) in 2020 to INR137.1bn (US$1.6bn) in 2025, majorly driven by quality-conscious and digitally savvy consumers, according to GlobalData, a leading data and analytics company. GlobalData’s report, ‘India Make-up – Market Assessment and […]
Read more
1 3 4 5 6 7 60